Michelle Ann Bulterys1, Patrick Oyaro1,2, Evelyn Brown3, Nashon Yongo3, Enericah Karauki3, James Wagude4, Leonard Kingwara5, Nancy Bowen5, Susan Njogo6, Anjuli D Wagner1, Irene Mukui1, Frederick Oluoch5, Lisa Abuogi7, Rena Patel1,8, Monisha Sharma1. 1. Departments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA. 2. Health Innovations Kenya, Kisumu, Kenya. 3. Department of HIV Research, University of Washington Kenya, Nairobi, Kenya. 4. Department of Health, Siaya County, Kenya. 5. National HIV Reference Laboratory, National Public Health Laboratory, Nairobi, Kenya. 6. National AIDS and STI Control Programme, Ministry of Health, Nairobi 19361, Kenya. 7. Department of Pediatrics, University of Colorado, Denver, CO 80045, USA. 8. Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98105, USA.
Abstract
BACKGROUND: The number of people living with HIV (PLHIV) in need of treatment monitoring in low-and-middle-income countries is rapidly expanding, straining existing laboratory capacity. Point-of-care viral load (POC VL) testing can alleviate the burden on centralized laboratories and enable faster delivery of results, improving clinical outcomes. However, implementation costs are uncertain and will depend on clinic testing volume. We sought to estimate the costs of decentralized POC VL testing compared to centralized laboratory testing for adults and children receiving HIV care in Kenya. METHODS: We conducted microcosting to estimate the per-patient costs of POC VL testing compared to known costs of centralized laboratory testing. We completed time-and-motion observations and stakeholder interviews to assess personnel structures, staff time, equipment costs, and laboratory processes associated with POC VL administration. Capital costs were estimated using a 5 year lifespan and a 3% annual discount rate. RESULTS: We estimated that POC VL testing cost USD $24.25 per test, assuming a clinic is conducting 100 VL tests per month. Test cartridge and laboratory equipment costs accounted for most of the cost (62% and 28%, respectively). Costs varied by number of VL tests conducted at the clinic, ranging from $54.93 to $18.12 per test assuming 20 to 500 VL tests per month, respectively. A VL test processed at a centralized laboratory was estimated to cost USD $25.65. CONCLUSION: POC VL testing for HIV treatment monitoring can be feasibly implemented in clinics within Kenya and costs declined with higher testing volumes. Our cost estimates are useful to policymakers in planning resource allocation and can inform cost-effectiveness analyses evaluating POC VL testing.
BACKGROUND: The number of people living with HIV (PLHIV) in need of treatment monitoring in low-and-middle-income countries is rapidly expanding, straining existing laboratory capacity. Point-of-care viral load (POC VL) testing can alleviate the burden on centralized laboratories and enable faster delivery of results, improving clinical outcomes. However, implementation costs are uncertain and will depend on clinic testing volume. We sought to estimate the costs of decentralized POC VL testing compared to centralized laboratory testing for adults and children receiving HIV care in Kenya. METHODS: We conducted microcosting to estimate the per-patient costs of POC VL testing compared to known costs of centralized laboratory testing. We completed time-and-motion observations and stakeholder interviews to assess personnel structures, staff time, equipment costs, and laboratory processes associated with POC VL administration. Capital costs were estimated using a 5 year lifespan and a 3% annual discount rate. RESULTS: We estimated that POC VL testing cost USD $24.25 per test, assuming a clinic is conducting 100 VL tests per month. Test cartridge and laboratory equipment costs accounted for most of the cost (62% and 28%, respectively). Costs varied by number of VL tests conducted at the clinic, ranging from $54.93 to $18.12 per test assuming 20 to 500 VL tests per month, respectively. A VL test processed at a centralized laboratory was estimated to cost USD $25.65. CONCLUSION: POC VL testing for HIV treatment monitoring can be feasibly implemented in clinics within Kenya and costs declined with higher testing volumes. Our cost estimates are useful to policymakers in planning resource allocation and can inform cost-effectiveness analyses evaluating POC VL testing.
Entities:
Keywords:
HIV care; HIV management; costing; point-of-care viral load testing; viral load test
Authors: Nicolas A Menzies; Andres A Berruti; Richard Berzon; Scott Filler; Robert Ferris; Tedd V Ellerbrock; John M Blandford Journal: AIDS Date: 2011-09-10 Impact factor: 4.177
Authors: Shirley Lecher; Jason Williams; Peter N Fonjungo; Andrea A Kim; Dennis Ellenberger; Guoqing Zhang; Christiane Adje Toure; Simon Agolory; Georgette Appiah-Pippim; Suzanne Beard; Marie Yolande Borget; Sergio Carmona; Geoffrey Chipungu; Karidia Diallo; Marie Downer; Dianna Edgil; Holly Haberman; Mackenzie Hurlston; Steven Jadzak; Charles Kiyaga; William MacLeod; Boniface Makumb; Hellen Muttai; Christina Mwangi; Jane W Mwangi; Michael Mwasekaga; Mary Naluguza; Lucy W Ng'Ang'A; Shon Nguyen; Souleymane Sawadogo; Katrina Sleeman; Wendy Stevens; Joel Kuritsky; Shannon Hader; John Nkengasong Journal: MMWR Morb Mortal Wkly Rep Date: 2016-12-02 Impact factor: 17.586
Authors: Sarah J Girdwood; Thomas Crompton; Monisha Sharma; Jienchi Dorward; Nigel Garrett; Paul K Drain; Wendy Stevens; Brooke E Nichols Journal: EClinicalMedicine Date: 2020-11-04
Authors: Monisha Sharma; Edinah Mudimu; Kate Simeon; Anna Bershteyn; Jienchi Dorward; Lauren R Violette; Adam Akullian; Salim S Abdool Karim; Connie Celum; Nigel Garrett; Paul K Drain Journal: Lancet HIV Date: 2020-12-18 Impact factor: 12.767
Authors: Bruce Larson; Kathryn Schnippel; Buyiswa Ndibongo; Lawrence Long; Matthew P Fox; Sydney Rosen Journal: PLoS One Date: 2012-04-20 Impact factor: 3.240
Authors: Minh D Pham; Lorena Romero; Bruce Parnell; David A Anderson; Suzanne M Crowe; Stanley Luchters Journal: AIDS Res Ther Date: 2017-01-19 Impact factor: 2.250
Authors: V Habiyambere; B Dongmo Nguimfack; L Vojnov; N Ford; J Stover; L Hasek; P Maggiore; D Low-Beer; M Pérez Gonzàlez; D Edgil; J Williams; J Kuritsky; S Hargreaves; T NeSmith Journal: PLoS One Date: 2018-09-19 Impact factor: 3.240
Authors: Sarah J Girdwood; Brooke E Nichols; Crispin Moyo; Thomas Crompton; Dorman Chimhamhiwa; Sydney Rosen Journal: PLoS One Date: 2019-08-26 Impact factor: 3.240
Authors: Rena C Patel; Patrick Oyaro; Beryne Odeny; Irene Mukui; Katherine K Thomas; Monisha Sharma; James Wagude; Eunice Kinywa; Frederick Oluoch; Francesca Odhiambo; Boaz Oyaro; Grace C John-Stewart; Lisa L Abuogi Journal: Contemp Clin Trials Commun Date: 2020-10-27
Authors: Rena C Patel; Patrick Oyaro; Katherine K Thomas; James Wagude; Irene Mukui; Evelyn Brown; Shukri A Hassan; Eunice Kinywa; Frederick Oluoch; Francesca Odhiambo; Boaz Oyaro; Leonard Kingwara; Enericah Karauki; Nashon Yongo; Lindah Otieno; Grace C John-Stewart; Lisa L Abuogi Journal: Lancet Child Adolesc Health Date: 2022-08-18
Authors: Eduard J Sanders; Clara Agutu; Elise van der Elst; Amin Hassan; Evanson Gichuru; Peter Mugo; Carey Farquhar; Joseph B Babigumira; Steven M Goodreau; Deven T Hamilton; Thumbi Ndung'u; Martin Sirengo; Wairimu Chege; Susan M Graham Journal: HIV Med Date: 2021-08-25 Impact factor: 3.094